Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update.
Charles AC, Digre KB, Goadsby PJ, Robbins MS, Hershey A; American Headache Society.
Headache. 2024 Apr;64(4):333-341. doi: 10.1111/head.14692. Epub 2024 Mar 11.
PMID:38466028
Vonoprazan: A New Potassium-Competitive Acid Blocker.
Comparative effects of drug interventions for the acute management of migraine episodes in adults: systematic review and network meta-analysis.
Karlsson WK, Ostinelli EG, Zhuang ZA, Kokoti L, Christensen RH, Al-Khazali HM, Deligianni CI, Tomlinson A, Ashina H, Ruiz de la Torre E, Diener HC, Cipriani A, Ashina M.